[BPO Insights] What a 53% Healthcare Revenue BPO Taught Me About Vertical Focus and AI Urgency

Last reviewed: February 2026

The CEO Who Showed Up to a Vendor Call

I've been on hundreds of evaluation calls with BPOs. The standard lineup is predictable: VP of Technology, Head of Digital Solutions, maybe an Operations Director. The CEO doesn't show up. CEOs have bigger things to do than evaluate AI vendors.

So when the CEO of a large BPO — thousands of seats, operations spanning multiple delivery centers — joined the very first AI evaluation call, I paid attention.

This wasn't a small operator where the CEO does everything by default. This was a company with a full leadership team, a structured procurement process, and a formal evaluation committee. The CEO had no operational reason to be on this call.

He had a strategic reason.

Fifty-three percent of his company's revenue came from healthcare clients.

Why 53% Changes Everything

Vertical concentration in BPOs isn't unusual. Many operators over-index in one or two verticals because that's where their expertise, relationships, and reputation are strongest. A 40/60 split across two verticals is common. A 30/30/40 split across three is healthy diversification.

But 53% in a single vertical is different. It creates a specific dynamic that I hadn't fully appreciated until this conversation.

When more than half your revenue depends on one industry, you don't have the luxury of watching that industry transform from a distance. Every trend, every disruption, every technology shift in that vertical is an existential question for your business.

Healthcare is in the middle of the most significant operational transformation in decades. Staffing shortages across clinical and administrative roles are structural, not cyclical. Patient expectations are being reset by consumer technology experiences. Regulatory pressure on cost transparency and patient access is intensifying. And AI is entering clinical and administrative workflows at an accelerating pace.

For a diversified BPO with 15% healthcare exposure, these trends are interesting. Worth monitoring. Something to discuss at the quarterly strategy offsite.

For a BPO with 53% healthcare exposure, these trends are the company. If healthcare clients shift their CX model, more than half the company's revenue is in play. Not theoretically in play. Actually in play, on a timeline measured in quarters, not years.

That's why the CEO was on the call.

The Signal from QBRs

The most revealing detail from the conversation wasn't about technology or pricing. It was about what was happening in quarterly business reviews.

Healthcare clients had started asking about AI in QBRs. Not as a future-state discussion. As a current-quarter question. "What's your AI strategy for our program?" "When can we see a pilot?" "Our competitors are deploying AI for patient scheduling — when can we?"

For a BPO, the QBR question is the most important signal in the business. It tells you what the client is thinking about renewing or not renewing. When clients ask about AI in QBRs, they're not making conversation. They're evaluating whether to keep you or find someone who has what they're asking for.

The BPO's CEO understood this instantly. His healthcare clients weren't asking if AI was relevant. They were asking when. And "we're evaluating options" was not an answer that would survive two more quarterly reviews.

He needed a specific answer: "We're deploying AI for your program starting in Q3. Here's what it looks like. Here are the metrics we'll measure." That answer required a platform partner, a deployment plan, and a timeline. Which is why the CEO was on a vendor evaluation call, personally, at a company with thousands of employees.

The Healthcare Background Advantage

There was another factor that made this operator different from most BPOs evaluating AI: the CEO came from healthcare, not from BPO.

This might seem like a biographical detail. It's actually a strategic advantage.

CEOs with healthcare backgrounds understand the specific constraints that make healthcare CX different from every other vertical. They know that healthcare systems run on software that was designed in the 1990s, with interfaces that were built for clinical documentation rather than patient interaction. They know that patient scheduling involves navigating a maze of provider availability, insurance eligibility, referral requirements, and facility-specific rules. They know that compliance isn't a checkbox — it's a daily operational reality with consequences measured in audit findings and potential fines.

This understanding meant the CEO asked the right questions in the evaluation. Not "what's your CSAT score?" but "can your AI navigate a desktop application without an API?" Not "what's your cost per interaction?" but "how do you handle PHI in voice interactions while maintaining compliance?" Not "show me a demo" but "show me it working inside a healthcare scheduling interface."

The evaluation skipped the generic discovery phase and went directly to the technical proof point that actually matters in healthcare: can the AI do what a human agent does when sitting in front of a healthcare application, reading screens, clicking buttons, filling forms, and navigating multi-step workflows?

The Contrast: Diversified BPOs Can Wait

Compare this urgency to a conversation I had the same week with a diversified BPO. Similar size. Similar client quality. But their revenue was spread across six verticals, with none exceeding 20%.

Their AI evaluation timeline? "We're forming an AI committee in Q3. We'll evaluate vendors in Q4. We expect to run a pilot in Q1 of next year. Full deployment decisions in mid-next-year."

That's a 12-18 month timeline before a single AI interaction reaches production. And nobody in the organization feels urgency to compress it. Because no single vertical is driving existential pressure. Healthcare is transforming, but it's only 18% of revenue. Retail is shifting, but it's only 15%. Financial services is evolving, but it's only 20%.

The diversified BPO has the luxury of thoughtful evaluation. The concentrated BPO has the pressure of survival.

Both operators will eventually deploy AI. But the concentrated operator will deploy 12-18 months sooner. And in a market where early deployment generates production data, client proof points, and competitive positioning, that time advantage compounds.

What This Means for BPO Strategy

The lesson isn't that concentration is better than diversification. In most business contexts, diversification reduces risk. But in a market undergoing technology transformation, concentration creates urgency that diversification dampens.

The concentrated BPO operator is forced to move fast because the alternative — losing 53% of revenue — is unacceptable. The diversified operator can afford to move slowly because no single vertical represents an existential threat.

But here's the counterintuitive implication: the concentrated operator's forced urgency becomes a strategic advantage. By deploying AI 12-18 months earlier, they build capabilities, generate case studies, and develop operational expertise that the diversified operator will eventually need but won't have.

The concentrated operator becomes the AI-ready BPO that commands a 2-3x valuation multiple. The diversified operator becomes the AI-lagging BPO that trades at 0.5-1x because they could afford to wait — and did.

The Decision Framework for Vertical BPOs

If you run a BPO with heavy concentration in a single vertical, here's the framework I'd use:

If your dominant vertical is actively being transformed by AI (healthcare, financial services, insurance): Treat AI deployment as a retention requirement, not an innovation initiative. Your clients are already asking. Your competitors are already deploying. Every quarter you delay is a quarter your clients spend evaluating alternatives.

If your dominant vertical has low AI adoption today but high potential (logistics, government services, utilities): You have a window of 12-18 months before client expectations shift. Use that window to deploy a pilot, generate data, and build capability before the urgency arrives.

If your dominant vertical has limited AI applicability in the near term: You have more time, but not unlimited time. Use the breathing room to evaluate platforms, complete compliance certifications, and position for the shift when it comes.

The CEO who joined that first evaluation call understood something that most BPO leaders haven't internalized yet: vertical concentration doesn't just create risk in an AI-transforming market. It creates a forcing function that, if acted upon, becomes the strongest competitive advantage a BPO can have.

Richard Lin is the CEO and founder of Anyreach, an agentic AI platform for enterprise CX.